<Anchor> The number
of people who received the vaccine exceeded 583,000, and 3 out of 4 people who were eligible for priority vaccination in the first quarter completed the vaccination.
From next month, general citizens aged 65 or older will also be vaccinated. As the number of targets increases rapidly, it is important to secure sufficient quantities.
This is reporter Kim Hyung-rae.
<Reporter>
Following the residents of nursing hospitals and facilities, and medical staff, general national vaccination will begin next month.
This target is for the general public over the age of 65, and it will be conducted sequentially, starting with the older person.
[Minister Jeon Hae-cheol/Ministry of Public Administration and Security: We are considering the elderly among the elderly over 65 years old, and from next week we will promptly proceed with the consent process for the target person by city, county, district, eup, myeon-dong.] The
key is securing the quantity of vaccines.
The government estimates that about 8.5 million people over the age of 65 are eligible to be vaccinated, and if they want to vaccinate them within two quarters as planned, in addition to the confirmed AstraZeneca vaccines of 4.55 million people and Pfizer vaccines of 3 million people, Modenawa has not yet confirmed the quantity. It is also necessary to secure enough vaccines such as Janssen.
In the meantime, the World Health Organization's WHO said in some cases of death due to blood clots after vaccinating AstraZeneca in some European countries, it is not related to the vaccine, and should continue to be vaccinated.
[Margaret Harris/World Health Organization (WHO) Spokesperson: So far, there have been no cases of death that have been proven to be due to vaccination.
Therefore, it should be clearly understood that we should continue to use the AZ vaccine.]
Our health authorities explained that the serial number of the vaccine was not introduced in Korea, and that there were no reports of side effects that a blood clot occurred in Korea.